https://www.thebodypro.com/category/hiv-treatment-strategies/tag/hepatitis-c

The Latest

hole in a fence

This Week in HIV Research: Removing Barriers to Better Care

Oct. 31, 2019: HCV treatment efficacy regardless of injection drug use; chronic pain, marijuana, and prescription opoids; the most urgent HIV training priorities; neuro effects of switching from Atripla to Complera.

couple on the boardwalk surrounded by seagulls

This Week in HIV Research: When STIs Flock Together

July 18, 2019: Anal neoplasia risk amidst comorbid HPV and chlamydia; predictive modeling for PrEP outreach; long-term benefits of hepatitis C cure in coinfection; first-line therapy with dolutegravir/lamivudine.

Close up of sneakers walking up stairs

This Week in HIV Research: One Step at a Time

June 13, 2019: Integrated stepped alcohol treatment in HIV clinics; cytokines, inflammation, and heart risk; impact of CCR5 gene editing on lifespan; the costs of "test and treat" for hepatitis C.

Doctor in hospital pharmacy looking at electronic chart

Antiviral Stewardship Program Reduces Medication Errors at a Veterans Affairs Hospital

When people living with HIV are admitted to a hospital, they may not be able to bring their medications with them, and could be prescribed new medication by a doctor who doesn't understand their complete medical history.

Promo Image

This Week in HIV Research: Additional Nuance on Pregnancy and Antiretrovirals

Switching HIV treatment regimens during the first trimester; drivers of viral breakthrough during pregnancy; HIV’s effect on liver risk after hepatitis C treatment; hepatic steatosis among young people with HIV.

Promo Image

This Week in HIV Research: Getting Smart(Phone) About HIV Detection

A cellphone attachment that detects HIV RNA; HIV-2 does indeed often progress to AIDS; CD4 count declines and incident hepatitis C coinfection; the global demographics of non-Hodgkin lymphoma.

Promo Image

This Week in HIV Research: Where Support Is Lacking, the Virus Can Spread

Housing, social support, and HIV transmissibility among people who use drugs; concerning hepatitis C incidence trends in France; frailty among people aging with HIV; untreated HIV and brain atrophy.

Promo Image

This Week in HIV Research: When Prioritizing Treatment, Look Beyond CD4

Gauging treatment priority when CD4 count is high; the effect of hepatitis C coinfection on response to HIV treatment; HIV, aging and comorbidity in Africa; PrEP and drug-resistant gonorrhea.

Hepatitis C and HIV Each Linked to Artery Plaque Buildup in Gay Men Img

Hepatitis C and HIV Each Linked to Artery Plaque Buildup in Gay Men

Hepatitis C (HCV) and HIV infection were independently associated with markers of subclinical atherosclerosis -- including plaque and coronary artery calcium -- in a study of 994 men who have sex with men.

Promo Image

African-American Women With HIV/HCV Less Likely to Die From Liver Disease

University of California San Francisco (UCSF) researchers have found that among women co-infected with HIV and hepatitis C virus (HCV), African Americans were less likely to die of liver disease. Of nearly 800 women enrolled in the Women's Interagenc...